{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T12:26:41Z","timestamp":1793968001077,"version":"4.8.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T00:00:00Z","timestamp":1710892800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Investigation"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.resinv.2024.03.003","type":"journal-article","created":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T11:21:55Z","timestamp":1711538515000},"page":"455-461","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Functional rescue of CFTR in rectal organoids from patients carrying R334W variant by CFTR modulators and PDE4 inhibitor Roflumilast"],"prefix":"10.1016","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6722-5683","authenticated-orcid":false,"given":"Roberta Valeria","family":"Latorre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2876-5809","authenticated-orcid":false,"given":"Martina","family":"Calicchia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Bigliardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Conti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1267-4814","authenticated-orcid":false,"given":"Karina","family":"Kleinfelder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5276-1595","authenticated-orcid":false,"given":"Paola","family":"Melotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2739-4014","authenticated-orcid":false,"given":"Claudio","family":"Sorio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.resinv.2024.03.003_bib1","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1126\/science.2475911","article-title":"Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA","volume":"245","author":"Riordan","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.resinv.2024.03.003_bib2","doi-asserted-by":"crossref","first-page":"a009498","DOI":"10.1101\/cshperspect.a009498","article-title":"The CFTR ion channel: gating, regulation, and anion permeation","volume":"3","author":"Hwang","year":"2013","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.resinv.2024.03.003_bib3","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1152\/physrev.1999.79.1.S23","article-title":"Structure and function of the CFTR chloride channel","volume":"79","author":"Sheppard","year":"1999","journal-title":"Physiol Rev"},{"key":"10.1016\/j.resinv.2024.03.003_bib4","first-page":"136","article-title":"Liver disease in cystic fibrosis","volume":"9","author":"Kobelska-Dubiel","year":"2014","journal-title":"Prz Gastroenterol"},{"key":"10.1016\/j.resinv.2024.03.003_bib5","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/GCO.0b013e32835f1745","article-title":"Cystic fibrosis and fertility","volume":"25","author":"Ahmad","year":"2013","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1016\/j.resinv.2024.03.003_bib6","unstructured":"Cystic Fibrosis Mutation Database availabe at: http:\/\/www.genet.sickkids.on.ca\/StatisticsPage.html."},{"key":"10.1016\/j.resinv.2024.03.003_bib7","unstructured":"The Clinical and Functional Translation of CFTR (CFTR2); available at: http:\/\/cftr2.org."},{"key":"10.1016\/j.resinv.2024.03.003_bib8","unstructured":"Cystic Fibrosis Foundation (CFF); available at: https:\/\/www.cff.org\/managing-cf\/cftr-modulator-therapies."},{"key":"10.1016\/j.resinv.2024.03.003_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/jpm12040632","article-title":"Theratyping of the rare CFTR variants E193K and R334W in rectal organoid-derived epithelial monolayers","volume":"12","author":"Ciciriello","year":"2022","journal-title":"J Pers Med"},{"key":"10.1016\/j.resinv.2024.03.003_bib10","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.abb.2004.03.033","article-title":"Maximization of the rate of chloride conduction in the CFTR channel pore by ion-ion interactions","volume":"426","author":"Gong","year":"2004","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.resinv.2024.03.003_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2023.1155705","article-title":"Personalized medicine: function of CFTR variant p.Arg334Trp is rescued by currently available CFTR modulators","volume":"10","author":"Railean","year":"2023","journal-title":"Front Mol Biosci"},{"key":"10.1016\/j.resinv.2024.03.003_bib13","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.jcf.2023.03.004","article-title":"FDA-approved drug screening in patient-derived organoids demonstrates potential of drug repurposing for rare cystic fibrosis genotypes","volume":"22","author":"de Poel","year":"2023","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.resinv.2024.03.003_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.518345","article-title":"Phosphodiesterase-4 inhibitors for non-COPD respiratory diseases","volume":"12","author":"Kawamatawong","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.resinv.2024.03.003_bib15","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1165\/rcmb.2013-0228OC","article-title":"Cystic fibrosis transmembrane conductance regulator activation by roflumilast contributes to therapeutic benefit in chronic bronchitis","volume":"50","author":"Lambert","year":"2014","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.resinv.2024.03.003_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0039809","article-title":"A pharmacologic approach to acquired cystic fibrosis transmembrane conductance regulator dysfunction in smoking related lung disease","volume":"7","author":"Sloane","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.resinv.2024.03.003_bib17","first-page":"846","article-title":"Dynamic activation of cystic fibrosis transmembrane conductance regulator by type 3 and type 4D phosphodiesterase inhibitors","volume":"314","author":"Liu","year":"2005","journal-title":"J Personalized Med"},{"key":"10.1016\/j.resinv.2024.03.003_bib18","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3389\/fphar.2020.00259","article-title":"Inhaled phosphodiesterase 4 (PDE4) inhibitors for inflammatory respiratory diseases","volume":"11","author":"Phillips","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.resinv.2024.03.003_bib19","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.3389\/fphar.2020.01135","article-title":"Phosphodiesterase 4 inhibitors in Allergic ahinitis\/rhinosinusitis","volume":"11","author":"Janosova","year":"2020","journal-title":"Front Pharmacol"},{"issue":"Suppl 1","key":"10.1016\/j.resinv.2024.03.003_bib11","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1016\/j.jcf.2019.11.002","article-title":"Intestinal organoids for cystic fibrosis research","volume":"19","author":"de Poel","year":"2020","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.resinv.2024.03.003_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24065199","article-title":"CFTR modulators rescue the activity of CFTR in rolonoids expressing the complex allele","volume":"24","author":"Kleinfelder","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.resinv.2024.03.003_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2020.100019","article-title":"Protocol for application, ctandardization and validation of the forskolin-induced swelling assay in cystic fibrosis suman holon organoids","volume":"1","author":"Vonk","year":"2020","journal-title":"STAR Protoc"},{"key":"10.1016\/j.resinv.2024.03.003_bib22","doi-asserted-by":"crossref","DOI":"10.3791\/55159-v","article-title":"Forskolin-induced swelling in intestinal organoids: an in vitro assay for assessing drug response in cystic fibrosis patients","author":"Boj","year":"2017","journal-title":"J Vis Exp"},{"key":"10.1016\/j.resinv.2024.03.003_bib23","doi-asserted-by":"crossref","first-page":"L908","DOI":"10.1152\/ajplung.00285.2019","article-title":"The dual phosphodiesterase 3\/4 inhibitor RPL554 stimulates rare class III and IV CFTR mutants","volume":"318","author":"Turner","year":"2020","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.resinv.2024.03.003_bib24","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1083\/jcb.143.3.645","article-title":"Cystic fibrosis transmembrane conductance regulator-associated ATP release is controlled by a chloride sensor","volume":"143","author":"Jiang","year":"1998","journal-title":"J Cell Biol"},{"key":"10.1016\/j.resinv.2024.03.003_bib25","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jcf.2010.06.001","article-title":"A high frequency of the Cystic Fibrosis 2184insA mutation in Western Ukraine: genotype-phenotype correlations, relevance for newborn screening and genetic testing","volume":"9","author":"Makukh","year":"2010","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.resinv.2024.03.003_bib26","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/MPA.0b013e3181967657","article-title":"Phenotype expression in a case of adult cystic fibrosis caused by an extremely rare compound heterozygous genotype (2183AA>G\/2789+5G>A)","volume":"38","author":"Capurso","year":"2009","journal-title":"Pancreas"},{"key":"10.1016\/j.resinv.2024.03.003_bib27","unstructured":"CFTRare; available at: https:\/\/cftr.iurc.montp.inserm.fr\/cftrare."},{"key":"10.1016\/j.resinv.2024.03.003_bib28","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01341-2022","article-title":"Rectal organoid-guided CFTR modulator therapy restores lung function in a cystic fibrosis patient with the rare 1677delTA\/R334W genotype","volume":"60","author":"Mitropoulou","year":"2022","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2024.03.003_bib29","first-page":"147","article-title":"Roflumilast: first phosphodiesterase 4 inhibitor approved for treatment of COPD","volume":"4","author":"Giembycz","year":"2010","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.resinv.2024.03.003_bib30","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/362160a0","article-title":"Mutations in CFTR associated with mild-disease-form Cl- channels with altered pore properties","volume":"362","author":"Sheppard","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.resinv.2024.03.003_bib31","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.201800172","article-title":"Folding-function relationship of the most common cystic fibrosis-causing CFTR conductance mutants","volume":"2","author":"van Willigen","year":"2019","journal-title":"Life Sci Alliance"},{"key":"10.1016\/j.resinv.2024.03.003_bib32","doi-asserted-by":"crossref","first-page":"18825","DOI":"10.1073\/pnas.0904709106","article-title":"Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770","volume":"106","author":"Van Goor","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.resinv.2024.03.003_bib33","doi-asserted-by":"crossref","first-page":"36639","DOI":"10.1074\/jbc.M112.393637","article-title":"Cystic fibrosis transmembrane conductance regulator (CFTR) potentiator VX-770 (ivacaftor) opens the defective channel gate of mutant CFTR in a phosphorylation-dependent but ATP-independent manner","volume":"287","author":"Eckford","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.resinv.2024.03.003_bib34","doi-asserted-by":"crossref","first-page":"4404","DOI":"10.1073\/pnas.1215982110","article-title":"Vx-770 potentiates CFTR function by promoting decoupling between the gating cycle and ATP hydrolysis cycle","volume":"110","author":"Jih","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.resinv.2024.03.003_bib35","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.3389\/fphar.2018.01048","article-title":"Phosphodiesterase-4 inhibitors for the treatment of inflammatory diseases","volume":"9","author":"Li","year":"2018","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.resinv.2024.03.003_bib36","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/s12931-019-1142-7","article-title":"Effect of the inhaled PDE4 inhibitor CHF6001 on biomarkers of inflammation in COPD","volume":"20","author":"Singh","year":"2019","journal-title":"Respir Res"},{"key":"10.1016\/j.resinv.2024.03.003_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pupt.2016.06.011","article-title":"A novel inhaled phosphodiesterase 4 inhibitor (CHF6001) reduces the allergen challenge response in asthmatic patients","volume":"40","author":"Singh","year":"2016","journal-title":"Pulm Pharmacol Ther"}],"container-title":["Respiratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212534524000455?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212534524000455?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T09:39:03Z","timestamp":1713346743000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212534524000455"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S2212534524000455"],"URL":"https:\/\/doi.org\/10.1016\/j.resinv.2024.03.003","relation":{},"ISSN":["2212-5345"],"issn-type":[{"value":"2212-5345","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Functional rescue of CFTR in rectal organoids from patients carrying R334W variant by CFTR modulators and PDE4 inhibitor Roflumilast","name":"articletitle","label":"Article Title"},{"value":"Respiratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.resinv.2024.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V. on behalf of The Japanese Respiratory Society.","name":"copyright","label":"Copyright"}]}}